@MIPserable

Homonormado 🏳️‍🌈 Muy hater.

 Locus coeruleus
Joined September 2010
  • Tweets38.8K
  • Following2.3K
  • Followers8.8K
4.4KMedia
- ¿Padece alguna enfermedad crónica? -No. -¿Toma algún medicamento? -Metformina, Lord-satan.
18
694
119
3,877
Metilfenidato se salió del grupo . retweeted
Sandra Sanchez, M.D.@SandraIxchelSOct 19
Gastric adenocarcinoma in the peritoneum! So many signet cells #cytopathology #pathology
1
16
1
56
1,792
Metilfenidato se salió del grupo . retweeted
SayedAlmahari@sayedalmahariOct 19
Basal cell adenoma is a benign salivary gland tumor, mainly of the parotid gland, with biphasic basaloid and ductal cells. It shows varied growth patterns, peripheral palisading, and nuclear β-catenin positivity at the periphery (CTNNB1 mutations). #pathology #pathtweet
5
24
484
Metilfenidato se salió del grupo . retweeted
Brian Garrigan 🇮🇪
@BrianGarriganOct 19
Europe where a white Woman is harassed by Islam for nor covering her self up.
5,872
7,845
1,278
27,731
4,173,360
Metilfenidato se salió del grupo . retweeted
Janira Navarro
@JaniranavarroOct 20
Recent data on ER low positive Up to 7000 patients with ER-low early stage breast cancer who received chemotherapy 42% omited endocrine therapy Those who omited had a 23% high risk of death, especially if they did not achived pCR or ER was 6-10% How to comment on ER-low positive resuts (pathology reports), pic 2 Dr. Allison. 2026 Diagnostic Pathology Update #USCAP #pathology #PathX
8
26
1,411
Metilfenidato se salió del grupo . retweeted
Dr Kings
@kingspsiquiatraOct 19
El TDAH no es solo un problema de la infancia. Es un trastorno del neurodesarrollo que causa dificultades para prestar atención o para controlar el impulso y la hiperactividad, y aunque antes se pensaba que se superaba al crecer, los estudios de seguimiento demuestran que en muchos casos los síntomas continúan en la vida adulta y afectan el trabajo, las relaciones y la salud. Por eso es importante reconocerlo y tratarlo también en adultos.
NEJM
@NEJMOct 19
ADHD is a neurodevelopmental disorder characterized by symptoms of inattention or hyperactivity–impulsivity. Although it has long been considered to be a childhood-limited condition, follow-up studies have shown a persistent course into adulthood. Learn more: nej.md/4s25aNL
A bullet list of key points from the Clinical Practice article “Adult Attention Deficit–Hyperactivity Disorder” on a yellow background. The New England Journal of Medicine identity sits at the bottom.

ALT A bullet list of key points from the Clinical Practice article “Adult Attention Deficit–Hyperactivity Disorder” on a yellow background. The New England Journal of Medicine identity sits at the bottom.

2
30
177
4,601
Metilfenidato se salió del grupo . retweeted
Yakup Ergün
@dr_yakupergunOct 19
Oncogenic mutations in non-small cell lung cancer: from molecular mechanisms to clinical practice A very comprehensive review👇 nature.com/articles/s41392-0…
48
113
6,587
Siempre paz
Roy Vázquez@RoyVazquez28Oct 18
Si no te suma, que no te consuma ✨
6
258
Metilfenidato se salió del grupo . retweeted
Janira Navarro
@JaniranavarroOct 18
When can HER2 IHC help in DCIS? In an intraductal proliferation with apocrine features and intermediate- to high-grade atypia Diffuse strong score 3+ HER2 staining supports DCIS and is not expected in hyperplasia HER2 does not help with low-grade DCIS, or with ADH vs borderline DCIS Dr. Allison. 2026 Diagnostic Pathology Update #USCAP #pathology #pathX
2
29
83
2,846
Metilfenidato se salió del grupo . retweeted
Janira Navarro
@JaniranavarroOct 17
Chemoprevention: Risk-reducing endocrine therapy is strongly recommended (NCCN) ADH/ALH = 86% reduction in breast cancer risk LCIS>50% reduction Dr. Allison. 2026 Diagnostic Pathology Update #USCAP #pathX #pathology
6
1
17
1,102
Metilfenidato se salió del grupo . retweeted
Jasmine Vickery@VickeryJasmineOct 15
Recently shared this interesting case at our interesting case conference and now want to share it with you all :) Core needle biopsy of a well circumscribed lesion in a pre-menopausal female #breastpath #pathx #pathtwitter #pathresidents
11
28
74
4,569
Metilfenidato se salió del grupo . retweeted
Arghya Bandyopadhyay@ArghyaBandyopa5Oct 16
5 days old male baby; large gastric tumor
5
11
3
59
4,193
Metilfenidato se salió del grupo . retweeted
Elizabeth Montgomery, MD@LizMontgomeryMDOct 16
Extra-nodal Rosai Dorfman disease shows overlapping features with IgG4-related fibrosclerosing disease - storiform fibrosis and inflammation. The S100 stain highlights emperipolesis with nuclear (short arrows) and cytoplasmic staining; engulfed cells are negative (long arrows).
2
35
96
2,902
Metilfenidato se salió del grupo . retweeted
Oncology Brothers
@OncBrothersOct 15
As we bring our “best options” upfront… what do you do if we do not see anticipated response to these neo-adjuvant Rx? Breast Cancer: After TDXd in NeoAdj… if there is gross residual disease… switch to TDM1? Continue w/ TDXd in Adj? @PTarantinoMD @hoperugo @drsarahsam @JavierCortesMD Bladder Cancer: After EV-Pembro… if there is minimal response… in Adj settings… continue with EV-Pembro? Consider Chemo? @PGrivasMDPhD @shilpaonc @tompowles1 @drenriquegrande
3
11
2
47
5,839
Metilfenidato se salió del grupo . retweeted
Janira Navarro
@JaniranavarroOct 16
Update of Surgical Management Recommendations for High-Risk Lesions of the Breast, part 2 Pure flat epithelial atypia (FEA): - No excision - Consider confirmatory 2nd review to exclude ADH - Consider excision if extensive calcifications or not adequatly sampled Dr. Allison. 2026 Diagnostic Pathology Update #USCAP #pathology #PathX
1
12
1
36
1,745
Metilfenidato se salió del grupo . retweeted
ARP Press
@ARP_PressOct 15
October is Breast Cancer Awareness Month, inspiring our case of the month: A 70yoW presents with a single, lobulated, retroareolar breast mass. A-B H&Es, C P63, D SMM-HC See the poll below - what's your diagnosis? Answer and discussion out in a couple of days! #BreastPath
1
6
1
13
1,323
Metilfenidato se salió del grupo . retweeted
Craig Horbinski
@CraigHorbinskiOct 15
One image is all you need to tell me the origin of this brain tumor. (Dive deep into the BOWELS of your #pathology knowledge base for this one.) #neuropath #pathtwitter
8
18
1
87
3,611
Metilfenidato se salió del grupo . retweeted
Janira Navarro
@JaniranavarroOct 15
Update on Surgical Management Recommendations for High-Risk Lesions of the Breast (American Society of Breast Surgeons) ADH: Surgical excision. Recommendation to do a confirmatory 2nd review (pathology) Exceptions: Patients who meet low-risk criteria may be considered for observation (see pic) Pathology low-risk criterion: - Focal ADH on pathology (what is considered focal? see pic below) Dr. Allison, 2026 Diagnostic Pathology Update #USCAP #pathology #PathX
15
30
1,927
Metilfenidato se salió del grupo . retweeted
Yakup Ergün
@dr_yakupergunOct 14
The FDA approved 22 new drugs in Q3 2026. Key oncology approvals: - Daraxonrasib - Gedatolisib - Camizestrant - Zidesamtinib - Lirafugratinib Daraxonrasib leads commercial forecasts, with projected annual sales of $6.6 billion by 2032. nature.com/articles/d41573-0…
2
24
78
5,503
Metilfenidato se salió del grupo . retweeted
Janira Navarro
@JaniranavarroOct 14
Breast Risk lesions Radiology standard (US): Referral to surgery if upgrade risk >3%. Dr. Allison. 2026 Diagnostic Pathology Update #USCAP #pathology #PathX
2
8
28
1,878
Metilfenidato se salió del grupo . retweeted
Raza Hoda, MD
@RazaHodaOct 12
Answer reveal: DCIS involving lobules! 🔬 DCIS creeping into lobules can mimic ALH, particularly when seen in isolation! The strong membranous E-cadherin staining confirms ductal differentiation. Thank you to all who joined our session at #IAP2026! #breastpath #PathTwitter
🤖 Made with AI
Raza Hoda, MD
@RazaHodaOct 9
What’s the diagnosis of this breast lesion? 🤔🔬 Poll in comments 👇 Answer reveal on Monday 🔮 📅 Specialty Conference 25 | Oct 11 | 6–8 PM 📍#IAP2026 | Fukuoka 🇯🇵 👨‍🏫 “Problems in Breast Pathology” Revisited #PathX #PathTwitter #breastpath #PathQuiz
2
5
31
1,291
Load more